D. Western Therapeutics Institute (TSE:4576) EV-to-FCF: (As of Jul. 08, 2026)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
44 GF Score
Price 円82.00
GF Value 円63.91
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, D. Western Therapeutics Institute's Enterprise Value is 円3,687.00 Mil. D. Western Therapeutics Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.00 Mil. Therefore, D. Western Therapeutics Institute's EV-to-FCF for today is .

The historical rank and industry rank for D. Western Therapeutics Institute's EV-to-FCF or its related term are showing as below:

TSE:4576' s EV-to-FCF Range Over the Past 10 Years
Min: -7.08   Med: 0   Max: 0
Current: -7.08

TSE:4576's EV-to-FCF is ranked worse than
100% of 327 companies
in the Biotechnology industry
Industry Median: 16.69 vs TSE:4576: -7.08

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-08), D. Western Therapeutics Institute's stock price is 円82.00. D. Western Therapeutics Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円-6.810. Therefore, D. Western Therapeutics Institute's PE Ratio (TTM) for today is At Loss.


D. Western Therapeutics Institute  (TSE:4576) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

D. Western Therapeutics Institute's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=82.00/-6.810
=At Loss

D. Western Therapeutics Institute's share price for today is 円82.00.
D. Western Therapeutics Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-6.810.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


D. Western Therapeutics Institute EV-to-FCF Related Terms


D. Western Therapeutics Institute EV-to-FCF Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute EV-to-FCF Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.65 -18.48 -5.90 -6.14 -8.26

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.14 0.00 0.00 -8.26 0.00

TSE:4576 vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, D. Western Therapeutics Institute's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D. Western Therapeutics Institute EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where D. Western Therapeutics Institute's EV-to-FCF falls into.


TSE:4576
44GF Score
D. Western Therapeutics Institute Inc TSE:4576
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute EV-to-FCF Calculation

D. Western Therapeutics Institute's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3687.001/0
=

D. Western Therapeutics Institute's current Enterprise Value is 円3,687.00 Mil.
D. Western Therapeutics Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円82.00 is trading 28.3% above its estimated GF Value™ of 円63.91. GuruFocus considers D. Western Therapeutics Institute to be Modestly Overvalued.

Key valuation signals for TSE:4576:

  • EV-to-FCF:
  • GF Value™: 円63.91 vs. price of 円82.00 (28.3% above fair value)
  • GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
44GF Score

Get the complete analysis for TSE:4576

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円82.00
Price
円63.91
GF Value